Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus

Journal of Clinical Microbiology

Volumn 41, Issue 1, 2003, Pages 5-14

  Cui, Longzhu ^a   Ma, Xiaoxue ^a   Sato, Katsuhiro ^a   Okuma, Keiko ^a   Tenover, Fred C ^h   Mamizuka, Elsa M ^b   Gemmell, Curtis G ^c   Kim, Mi Na ^d   Ploy, Marie Cecile ^e   El Solh, N ^f   Ferraz, Vivian ^g   Hiramatsu, Keiichi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d University of Ulsan College of Medicine   (South Korea)

^e DUPUYTREN UNIVERSITY HOSPITAL   (France)

^f INSTITUT PASTEUR   (France)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; GLYCOPEPTIDE; IMIPENEM; OXACILLIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM MUTANT; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; THICKNESS;

ANTI-BACTERIAL AGENTS; CELL WALL; ELECTROPHORESIS, GEL, PULSED-FIELD; GLYCOPEPTIDES; HUMANS; LACTAMS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 12244312162     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.1.5-14.2003     Document Type: Article

References (35)

1. Aritaka, N., H. Hanaki, L. Cui, and K. Hiramatsu. 2001. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob. Agents Chemother. 45:1292-1294.
2. Boyle-Vavra, S., S. K. Berke, J. C. Lee, and R. S. Daum. 2000. Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates. Antimicrob. Agents Chemother. 44:272-277.
3. Boyle-Vavra, S., H. Labischinski, C. C. Ebert, K. Ehlert, and R. S. Daum. 2001. A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 45:280-287.
4. Breukink, E., I. Wiedemann, C. van Kraaij, O. Kuipers, H. Sahl, and B. de Kruijff. 1999. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286:2361-2364.
5. Chesneau, O., A. Morvan, and N. E. Solh. 2000. Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. J. Antimicrob. Chemother. 45:887-890.
6. Cui, L., H. Murakami, K. Kuwahara-Arai, H. Hanaki, and K. Hiramatsu. 2000. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob. Agents Chemother. 44:2276-2285.
7. Ferraz, V., A. Duse, M. Kassel, A. Black, T. Ito, and K. Hiramatsu. 2000. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S. Afr. Med. J. 90:1113.
8. Finan, J., A. Rosato, T. Dickinson, D. Ko, and G. Archer. 2002. Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression. Antimicrob. Agents Chemother. 46:24-30.
9. Fridkin, S. K. 2001. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin. Infect. Dis. 32:108-115.
10. Hageman, J., D. Pegues, C. Jepson, R. Bell, M. Guinan, K. Ward, M. Cohen, J. Hindler, F. Tenover, S. McAllister, M. Kellum, and S. Fridkin. 2001. Vancomycin-intermediate Staphylococcus aureus in a home health-care patient. Emerg. Infect. Dis. 7:1023-1025.
11. Hanaki, H., K. Kuwahara-Arai, S. Boyle-Vavra, R. S. Daum, H. Labischinski, and K. Hiramatsu. 1998. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J. Antimicrob. Chemother. 42:199-209.
12. Hanaki, H., H. Labischinski, Y. Inaba, N. Kondo, H. Murakami, and K. Hiramatsu. 1998. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. J. Antimicrob. Chemother. 42:315-320.
13. Hiramatsu, K. 1998. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am. J. Med. 104:7S-10S.
14. Hiramatsu, K. 1998. Vancomycin resistance in Staplylococci. Drug Resist. 1:135-150.
15. Hiramatsu, K. 2001. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1:147-155.
16. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
17. Hiramatsu, K., T. Ito, and H. Hanaki. 1999. Mechanisms of methicillin and vancomycin resistance in Staphylococcus aureus, p. 211-242. In W. R. G. Finch and R. J. Williams (ed.), Bailliere's clinical infectious diseases, vol. 5. Bailliere Tindall, London, United Kingdom.
18. Hood, J., G. F. S. Edwards, B. Cosgrove, E. Curran, D. Morrison, and C. G. Gemmell. 2000. Vancomycin-intermediate Staphylococcus aureus at a Scottish hospital. J. Infect. 40:A11.
19. Kim, M. N., C. H. Pai, J. H. Woo, J. S. Ryu, and K. Hiramatsu. 2000. Vancomycin-intermediate Staphylococcus aureus in Korea. J. Clin. Microbiol. 38:3879-3881.
20. Oliveira, G. A., A. M. Aquila, R. A. Masiero, C. Levy, S. G. Gomes, L. Cui, K. Hiramatsu, and E. M. Mamizuka. 2001. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect. Control Hosp. Epidemiol. 22:443-448.
21. Paton, R., T. Snell, F. Emmanuel, and R. Miles. 2001. Glycopeptide resistance in an epidemic strain of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 48:941-942.
22. Prescott, L., J. Harley, and D. Klein. 1990. Microbial growth, p. 110-114. In K. Kane (ed.), Microbiology. Wm. C. Brown Publisher, Dubuque, Iowa.
23. Reynolds, P., and E. Somner. 1990. Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics. Drugs Exp. Clin. Res. 16:385-389.
24. Sieradzki, K., M. G. Pinho, and A. Tomasz. 1999. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. 274:18942-18946.
25. Sieradzki, K., R. B. Roberts, S. W. Haber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340:517-523.
26. Smith, T. L., M. L. Pearson, K. R. Wilcox, C. Cruz, M. V. Lancaster, B. Robinson-Dunn, F. C. Tenover, M. J. Zervos, J. D. Band, E. White, and W. R. Jarvis. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus. N. Engl. J. Med. 340:493-501.
27. Tanaka, T., K. Okuzumi, A. Iwamoto, and K. Hiramatsu. 1995. A retrospective study of methicillin-resistant Staphylococcus aureus clinical strains in Tokyo University Hospital. J. Infect. Chemother. 1:40-49.
28. Tenover, F., R. Arbeit, R. Goering, P. Mickelsen, B. Murray, D. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
29. Tenover, F. C. 1999. Implications of vancomycin-resistant Staphylococcus aureus. J. Hosp. Infect. 43(Suppl.):S3-S7.
30. Tenover, F. C., J. W. Biddle, and M. V. Lancaster. 2001. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg. Infect. Dis. 7:327-332.
31. Tenover, F. C., M. V. Lancaster, B. C. Hill, C. D. Steward, S. A. Stocker, G. A. Hancock, C. M. O'Hara, S. K. McAllister, N. C. Clark, and K. Hiramatsu. 1998. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36:1020-1027.
32. Walsh, C. 1999. Deconstructing vancomycin. Science 284:442-443.
33. Wong, S. S., T. K. Ng, W. C. Yam, D. N. Tsang, P. C. Woo, S. K. Fung, and K. Y. Yuen. 2000. Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin. Diagn. Microbiol. Infect. Dis. 36:261-268.
34. Wong, W., A. Chatterjee, and F. Young. 1978. Regulation of bacterial cell walls: correlation between autolytic activity and cell wall turnover in Staphylococcus aureus. J. Bacteriol. 134:555-561.
35. Yoshida, T., N. Kondo, Y. A. Hanifah, and K. Hiramatsu. 1997. Combined use of ribotyping, PFGE typing and IS431 typing in the discrimination of nosocomial strains of methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 41:687-695.